首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >The Magnitude of the Association between Fluoroquinolone Use and Quinolone-Resistant Escherichia coli and Klebsiella pneumoniae May Be Lower than Previously Reported
【2h】

The Magnitude of the Association between Fluoroquinolone Use and Quinolone-Resistant Escherichia coli and Klebsiella pneumoniae May Be Lower than Previously Reported

机译:氟喹诺酮类药物使用与耐喹诺酮类大肠杆菌和肺炎克雷伯菌的关联强度可能低于以前的报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Case-control analyses of resistant versus susceptible isolates have implicated fluoroquinolone exposure as a strong risk factor for fluoroquinolone-resistant isolates of Enterobacteriaceae. We suspect that such methodology may overestimate this association. A total of 84 cases with fluoroquinolone-resistant isolates and 578 cases with fluoroquinolone-susceptible isolates of Escherichia coli or Klebsiella pneumoniae were compared with 608 hospitalized controls in parallel multivariable analyses. For comparison of previous estimates, the results of 10 published case-control studies of risk for fluoroquinolone resistance in isolates of Enterobacteriaceae were pooled by using a random-effects model. Exposure to fluoroquinolones was significantly positively associated with fluoroquinolone resistance (odds ratio [OR], 3.17) and negatively associated with fluoroquinolone susceptibility (OR, 0.18). Multivariable analyses yielded similar estimates (ORs, 2.04 and 0.10, respectively). As data on antibiotic exposure were limited to inpatient prescriptions, misclassification of fluoroquinolone exposure in persons who received fluoroquinolones as outpatients may have led to an underestimation of the true effect size. Pooling the results of previously published studies in which a direct comparison of fluoroquinolone-resistant and fluoroquinolone-susceptible cases was used resulted in a markedly higher effect estimate (OR, 18.7). Had we directly compared resistant and susceptible cases, our univariate OR for the association between fluoroquinolone use and the isolation of resistant Enterobacteriaceae would have been 19.3, and the multivariate OR would have been 16.5. Fluoroquinolone use is significantly associated with the isolation of fluoroquinolone-resistant Enterobacteriaceae; however, previous studies likely exaggerated the magnitude of this association.
机译:对耐药菌株和易感菌株的病例对照分析表明,氟喹诺酮暴露是肠杆菌科耐药氟喹诺酮菌株的重要危险因素。我们怀疑这种方法可能高估了这种关联。在平行多变量分析中,将总共84例耐氟喹诺酮耐药菌株和578例氟喹诺酮敏感菌株的大肠杆菌或肺炎克雷伯菌与住院的608例对照进行了比较。为了与先前的估计进行比较,使用随机效应模型汇总了10篇已发表的案例分析研究肠杆菌科细菌对氟喹诺酮耐药的风险。氟喹诺酮类药物的暴露与氟喹诺酮类药物耐药性呈显着正相关(比值比[OR],3.17),与氟喹诺酮类药物敏感性呈负相关(OR,0.18)。多变量分析得出相似的估计值(OR分别为2.04和0.10)。由于有关抗生素暴露的数据仅限于住院处方,因此在接受氟喹诺酮类药物的患者中门诊患者对氟喹诺酮类药物的暴露分类错误可能导致对实际效应大小的低估。汇总以前发表的研究结果,其中直接比较了对氟喹诺酮耐药和氟喹诺酮敏感的病例,得出的疗效估计值明显更高(OR,18.7)。如果我们直接比较耐药和易感病例,则氟喹诺酮使用与耐药肠杆菌科细菌分离之间的相关性的单变量OR为19.3,多变量OR为16.5。氟喹诺酮类药物的使用与耐氟喹诺酮类肠杆菌科细菌的分离显着相关。但是,先前的研究可能会夸大这种关联的程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号